GL1X · GenesisL1 explorer

MolNFT v1 · #189692 · protein

Inward-facing structure of human EAAT2 in the WAY213613-bound state

7VR7 · Excitatory amino acid transporter 2: “Inward-facing structure of human EAAT2 in the WAY213613-bound state”. Electron microscopy, 4 ligands (CLR, PC1, GJ0), 6 pockets (best druggability 0.74). MolNFT v1 #189692 on GenesisL1: 3D…

PDB
7VR7
Type
protein
Length
402 residues
Chains
1
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Excitatory amino acid transporter 2
UniProt
P43004
Ligands
CLR, PC1, GJ0, 9Z9
Pockets
6 · best druggability 0.74

Structure

electron microscopy · 1 distinct chain · 80% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AExcitatory amino acid transporter 2protein40280% helix, 3% strandP43004

Ligands and binding sites

  • CLR · Cholesterol · ligand · 2 copies · chains A
  • PC1 · 1,2-diacyl-sn-glycero-3-phosphocholine · ligand · 2 copies · chains A
  • GJ0 · (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl) phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid · ligand · chains A
  • 9Z9 · (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14730.740.8338GJ0
23730.700.81369Z9
31110.600.8623empty
4750.370.7614CLR
5810.360.7516empty

Compared structures

  • 7VR7 · Inward-facing structure of human EAAT2 in the WAY213613-bound state · the same entry in another collection · chain A against A, TM-score 1.00
  • P43004 · AlphaFold monomer V2.0 prediction for excitatory amino acid transporter 2 (P43004) · a predicted model of the same protein · chain A against A, TM-score 0.63

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.